ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Methotrexate

Also written as “methotrexate”, “Methotrexate (MTX)” and “MTX”.

Its studies are mostly in Arthritis, Rheumatoid · Psoriasis · Gout · Arthritis, Psoriatic · Arthritis, Juvenile, led by 24 companies.

Drug pageMethotrexate: every studyMany companies study it; this page follows only the 93 they lead. All 627 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Apr 18, 200793 company-led studies, 4 open or runningNext primary completion: Nov 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Hoffmann-La Roche360 open or runningphase 4since Apr 18, 2007Oct 21, 2005none ahead
Bristol-Myers Squibbits history only91 open or runningphase 4since Sep 4, 2015Jul 19, 2005none ahead
Pfizerits history only80 open or runningphase 4since Sep 8, 2005Sep 8, 2005none ahead
AbbVieits history only60 open or runningphase 4since May 25, 2010Sep 13, 2005none ahead
Johnson & Johnsonits history only60 open or runningphase 3since Dec 11, 2005Dec 11, 2005none ahead
Aldeyra Therapeuticsits history only31 open or runningphase 3since Oct 21, 2019Oct 21, 2019Dec 2029phase 3 · NCT07402876
AstraZenecaits history only30 open or runningphase 4since Aug 23, 2023Sep 16, 2005none ahead
medacits history only31 open or runningphase 3since Jan 11, 2024May 14, 2013Nov 2026phase 3 · NCT06239311
Merckits history only30 open or runningphase 3since Aug 18, 2006Aug 18, 2006none ahead
Halozyme Therapeuticsits history only20 open or runningphase 2since Jun 4, 2012Jun 4, 2012none ahead

Also a collaborator on its studies: Lakefront Biotherapeutics NV, Roche Pharma, Regeneron Pharmaceuticals, Integrated Therapeutics Group, Accutest Research Laboratories (I) Pvt., PPD DEVELOPMENT, LP, UCB, Immunex, Basilea Pharmaceutica International, Tanabe Pharma, Astellas Pharma US and Eisai.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Hoffmann-La Roche only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 20 studies since Oct 21, 2005.

  1. Oct 15, 2010Phase 3 study in Arthritis, RheumatoidNCT01235507 · 71 enrolled · Bosnia and Herzegovina
  2. Dec 8, 2010Phase 3 study in Arthritis, RheumatoidNCT01258712 · 86 enrolled · Taiwan
  3. May 3, 20112 phase 3 studies in Arthritis, RheumatoidNCT01347983, NCT01353859
  4. Jul 20, 2011Phase 4 study in Arthritis, RheumatoidNCT01399697 · 261 enrolled · Spain
  5. Mar 12, 2012Phase 3 study in Arthritis, RheumatoidNCT01587989 · 77 enrolled · Austria
  6. Aug 7, 2012Phase 4 study in Arthritis, RheumatoidNCT01661140 · 427 enrolled · United Kingdom
  7. May 14, 2013Phase 3 study in Arthritis, RheumatoidNCT01855789 · 718 enrolled · United States
  8. Jun 6, 2013Phase 4 study in Arthritis, RheumatoidNCT01878318
  9. Aug 30, 2013Phase 3 study in Arthritis, RheumatoidNCT01941095 · 100 enrolled · Greece
  10. Nov 1, 20132 phase 3 studies in Arthritis, RheumatoidNCT01995201, NCT01987479
  11. Dec 5, 2013Phase 3 study in Arthritis, RheumatoidNCT02006706 · 15 enrolled · Serbia
  12. Feb 23, 2016Phase 2 study in Arthritis, RheumatoidNCT02693210 · 161 enrolled · Australia, Belgium, Canada and more
  13. Mar 1, 2016Phase 1 study in Healthy VolunteerNCT02699710 · 50 enrolled · United Kingdom
  14. May 15, 2017Phase 3 study in Arthritis, RheumatoidNCT03155347 · 340 enrolled · China

TargetBeta

DHFR →read by rule
“Dihydrofolate reductase inhibitor; Dihydrofolate reductase inhibitor”ChEMBL 37, by rule

Other programs on DHFR

ProgramCompanyFurthest phaseStudies
PemetrexedruleEli Lillyphase 4141
pralatrexateruleAurobindo Pharmaphase 419

Studies

All 36 Hoffmann-La Roche leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT03155347Arthritis, Rheumatoid · China3CompletedAug 8, 2022340
NCT02699710Healthy Volunteer · United Kingdom1CompletedMay 26, 201650
NCT02693210Arthritis, Rheumatoid · Australia, Belgium, Canada and more2CompletedAug 2002161
NCT02006706Arthritis, Rheumatoid · Serbia3CompletedNov 23, 200715
NCT01987479Arthritis, Rheumatoid · Netherlands3CompletedMay 26, 2016150
NCT01995201Arthritis, Rheumatoid · Ireland, Portugal, Spain3CompletedJul 2015401
NCT01941095Arthritis, Rheumatoid · Greece3CompletedJul 10, 2016100
NCT01878318Arthritis, Rheumatoid4WithdrawnJun 20150
NCT01855789Arthritis, Rheumatoid · United States3CompletedOct 14, 2016718
NCT01661140Arthritis, Rheumatoid · United Kingdom4TerminatedFeb 2015427
NCT01587989Arthritis, Rheumatoid · Austria3CompletedFeb 201477
NCT01399697Arthritis, Rheumatoid · Spain4CompletedMay 2014261
NCT01353859Arthritis, Rheumatoid · Indonesia3CompletedJul 201239
NCT01347983Arthritis, Rheumatoid · Taiwan3CompletedMar 201372
NCT01258712Arthritis, Rheumatoid · Taiwan3CompletedOct 201286
NCT01235507Arthritis, Rheumatoid · Bosnia and Herzegovina3CompletedDec 201271
NCT01163747Arthritis, Rheumatoid · United States4CompletedDec 201191
NCT01063062Arthritis, Rheumatoid · Egypt3CompletedJan 17, 2011107
NCT01034137Arthritis, Rheumatoid · Netherlands3CompletedSep 2014317
NCT01007435Arthritis, Rheumatoid · United States, Argentina, Australia and more3CompletedMay 31, 20121,162
NCT01000610Arthritis, Rheumatoid · Tunisia4CompletedMay 16, 201218
NCT00965653Arthritis, Rheumatoid · Canada, New Zealand, Spain1Completed29
NCT00934648Arthritis, Rheumatoid · Morocco4CompletedNov 201015
NCT00810199Arthritis, Rheumatoid · United States, Brazil, Croatia and more3CompletedAug 2010556
NCT00754572Arthritis, Rheumatoid · Argentina, Brazil, Chile and more3CompletedOct 2012418
NCT00576433Arthritis, Rheumatoid · Russian Federation4CompletedNov 201060
NCT00517699Lymphoma · Canada2TerminatedMar 20095
NCT00504777Arthritis, Rheumatoid · Taiwan4CompletedMar 201036
NCT00502996Arthritis, Rheumatoid · Argentina, Brazil, Chile and more3CompletedDec 2008246
NCT00502853Arthritis, Rheumatoid · Italy4CompletedJul 23, 201010
NCT00485589Arthritis, Rheumatoid3TerminatedJan 29, 2010613
NCT00462345Arthritis, Rheumatoid · Korea, Republic of4CompletedJul 200940
NCT00422942Arthritis, Rheumatoid · Netherlands2TerminatedJun 20103
NCT00365001Arthritis, Rheumatoid · United States, New Zealand1Completed23
NCT00299130Arthritis, Rheumatoid3CompletedJun 2008511
NCT00243412Arthritis, Rheumatoid2CompletedFeb 200942

How it is read

Names in the registry

  • “Methotrexate”, 71 entries
  • “methotrexate”, 28 entries
  • “Methotrexate (MTX)”, 7 entries
  • “MTX”, 4 entries
  • “methotrexate (MTX)”, 3 entries

Codes read as this program: ADX2191.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.